googlemarker
Open An Account
Secure With Us
Trade on Mobile

AUROBINDO PHARMA LTD.

NSE : AUROPHARMABSE : 524804ISIN CODE : INE406A01037Industry : Pharmaceuticals & Drugs MCap (Rs. in Mn) : 341027.52 Face Value (Rs.) : 1 House : Aurobindo
BSE582.0513 (+2.28 %)
PREV CLOSE (Rs.) 569.05
OPEN PRICE (Rs.) 571.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 581.95 (131)
VOLUME 107198
TODAY'S LOW / HIGH (Rs.)567.55 587.95
52 WK LOW / HIGH (Rs.)527.05 808.95
NSE583.8015.95 (+2.81 %)
PREV CLOSE( Rs. ) 567.85
OPEN PRICE (Rs.) 568.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 583.80 (11026)
VOLUME 1676065
TODAY'S LOW / HIGH(Rs.) 566.75 589.45
52 WK LOW / HIGH (Rs.)527 809.45
1D 1M 3M 1Y 3Y 5Y
Trade Value (Rs. in Lacs)
621.79
Dividend Yield(%)
0.43
TTM EPS (Rs.)
30.94
P/E Ratio
18.81
Book Value (Rs.)
170.38
Face Value (Rs.)
1
MCap (Rs. in Mn)
341027.52
Price/Earning (TTM)
15.73
Price/Sales (TTM)
3.40
Price/Book (MRQ)
3.42
PAT Margin (%)
17.45
ROCE (%)
19.75
Incorporation Year : 26-12 1986

Management Info :

K Ragunathan - Chairman N Govindarajan - Managing Director

Registered Office :

Address : Plot No. 2,Maitrivihar ,Ameerpet,
Hyderabad,
Telangana-500038

Phone : +91-040-66725000

Website : www.aurobindo.com

Registrars Details :

Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
16Jul Announcement under Regulation 30 (LOD
Aurobindo signs a definitive Agreement to acquire Apotex' businesses in..
16Jul Aurobindo Pharma, Bank of Baroda and K
Aurobindo Pharma has entered into a definite agreement with global gener..
16Jul Aurobindo Pharma’s arm enters into agr
Aurobindo Pharma’s wholly owned step-down subsidiary -- Agile Pharma BV..
QTR Mar 18 ANNUAL 18
Net Profit3082.918127.7
Gross Profit 3752.8 23429.4
Operating Profit 4842.4 27506.6
Net Sales 23547.2 103031.5
Rs. in Millions
Ajanta Pharma (BSE)
img  1017.95 (4.87%)
M.Cap (Rs. in Cr)8959.54
Abbott India (BSE)
img  7305.80 (0.42%)
M.Cap (Rs. in Cr)15524.32
Dr. Reddys Lab (BSE)
img  2055.60 (1.22%)
M.Cap (Rs. in Cr)34122.72
Zim Laboratories (BSE)
img  385.00 (4.90%)
M.Cap (Rs. in Cr)310.30
PROMOTERS
51.87%
MUTUAL FUNDS/UTI
15.23%
NON-INSTITUTION
14.53%
FI/BANKS/INSURANCE
0.59%
GOVERNMENT
0%
FII
0%
Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day.....Issued in the interest of investors.  |  No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. |  KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Dear Client, Pursuant to SEBI regulation, update your KYC details through KRA form with supporting documents at earliest to complete KYC-KRA requirement. If already submitted, kindly ignore. For any information, in this regard, please contact to our KYC Department on 022-66556772/73/74 or email at kyc@satco.co.in.
  • NSE - INZ 230012635 | 
  • BSE - INZ 010012839 | 
  • MCX - IN2000026431 / FMC : MCX/TCM/CORP/0598  | 
  • NCDEX - IN2000026431 / FMC : NCDEX/TM/CORP/1138 | 
  • CDSL – IN-DP-CDSL-727-2014  | 
  • PMS - INP000003492  | 
  • RESEARCH – INH000002343
  • © Copyright 2015. SATCO CAPITAL MARKETS LTD. || Designed Developed & Content Powered By Accord Fintech Pvt.Ltd.
VISIT COUNT     912557